Human Vaccines: Emerging Technologies in Design and Development
()
About this ebook
Human Vaccines: Emerging Technologies in Design and Development discusses the advances in molecular biology, biophysics, and informatics—among other disciplines—that have provided scientists with the tools to create new vaccines against emerging and re-emerging pathogens.
For example, the virus-like particle technologies that led to licensing of highly efficacious HPV vaccines have only come into full realization in the last 10 years. Their success has, in turn, accelerated the pace with which nanoparticle vaccines are being developed
Given the rapidity with which the field is changing and the absence of any text documenting this change, there is a need for a resource that surveys these new vaccine technologies, assesses their potential, and describes their applications. This book provides that resource and complements traditional vaccinology books, but also serves as an excellent standalone for researchers and students with basic knowledge in immunology.
- Introduces new topics in vaccine immunology in the context vaccine design and production
- Consolidates the growing body of knowledge on new vaccine technologies that have only emerged in the past 2 – 3 decades
- Reviews the currently licensed vaccines that have utilized leading-edge technologies and how this has translated into improved efficacy and safety
- Provides a broad overview of innovative vaccine technologies, including immunological aspects
Related to Human Vaccines
Related ebooks
Vaccines: New Approaches to Immunological Problems Rating: 5 out of 5 stars5/5Harnessing the Power of Viruses Rating: 0 out of 5 stars0 ratingsNonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics Rating: 0 out of 5 stars0 ratingsNanoparticles and the Immune System: Safety and Effects Rating: 0 out of 5 stars0 ratingsCancer Treatment and the Ovary: Clinical and Laboratory Analysis of Ovarian Toxicity Rating: 0 out of 5 stars0 ratingsiPSCs for Studying Infectious Diseases Rating: 5 out of 5 stars5/5Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives Rating: 0 out of 5 stars0 ratingsVaccinology and Methods in Vaccine Research Rating: 0 out of 5 stars0 ratingsA New History of Vaccines for Infectious Diseases: Immunization - Chance and Necessity Rating: 0 out of 5 stars0 ratingsMaternal Immunization Rating: 0 out of 5 stars0 ratingsThe Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry Rating: 5 out of 5 stars5/5The Microbiology of Central Nervous System Infections Rating: 0 out of 5 stars0 ratingsGene Therapy for Viral Infections Rating: 5 out of 5 stars5/5Immunopathology, Diagnosis and Treatment of HPV induced Malignancies Rating: 5 out of 5 stars5/5The Vaccine Book Rating: 4 out of 5 stars4/5Vaccination Investigation: The History and Science of Vaccines Rating: 5 out of 5 stars5/5Anti/Vax: Reframing the Vaccination Controversy Rating: 5 out of 5 stars5/5The Pharmaceutical Myth: Letting Food be Your Medicine is the Answer for Perfect Health Rating: 0 out of 5 stars0 ratingsMicro- and Nanotechnology in Vaccine Development Rating: 0 out of 5 stars0 ratingsHuman Papillomavirus Vaccine Rating: 5 out of 5 stars5/5The Big Autism Cover-Up: How and Why the Media Is Lying to the American Public Rating: 1 out of 5 stars1/5The Panic Virus: A True Story of Medicine, Science, and Fear Rating: 4 out of 5 stars4/5Not Quite a Cancer Vaccine: Selling HPV and Cervical Cancer Rating: 5 out of 5 stars5/5Principles of Translational Science in Medicine: From Bench to Bedside Rating: 0 out of 5 stars0 ratingsAntibiotics: Origin, Nature and Properties Rating: 3 out of 5 stars3/5The Vaccine Court: The Dark Truth of America's Vaccine Injury Compensation Program Rating: 5 out of 5 stars5/5Immunopotentiators in Modern Vaccines Rating: 0 out of 5 stars0 ratingsAutoimmune Disease Models Rating: 0 out of 5 stars0 ratings
Medical For You
The Song of the Cell: An Exploration of Medicine and the New Human Rating: 4 out of 5 stars4/5The Vagina Bible: The Vulva and the Vagina: Separating the Myth from the Medicine Rating: 5 out of 5 stars5/5What Happened to You?: Conversations on Trauma, Resilience, and Healing Rating: 4 out of 5 stars4/5Mediterranean Diet Meal Prep Cookbook: Easy And Healthy Recipes You Can Meal Prep For The Week Rating: 5 out of 5 stars5/5The Emperor of All Maladies: A Biography of Cancer Rating: 5 out of 5 stars5/5Brain on Fire: My Month of Madness Rating: 4 out of 5 stars4/5Mating in Captivity: Unlocking Erotic Intelligence Rating: 4 out of 5 stars4/5Holistic Herbal: A Safe and Practical Guide to Making and Using Herbal Remedies Rating: 4 out of 5 stars4/5Herbal Healing for Women Rating: 4 out of 5 stars4/5Gut: The Inside Story of Our Body's Most Underrated Organ (Revised Edition) Rating: 4 out of 5 stars4/5Adult ADHD: How to Succeed as a Hunter in a Farmer's World Rating: 4 out of 5 stars4/5WomanCode: Perfect Your Cycle, Amplify Your Fertility, Supercharge Your Sex Drive, and Become a Power Source Rating: 4 out of 5 stars4/5Living Daily With Adult ADD or ADHD: 365 Tips o the Day Rating: 5 out of 5 stars5/5Women With Attention Deficit Disorder: Embrace Your Differences and Transform Your Life Rating: 5 out of 5 stars5/5The Diabetes Code: Prevent and Reverse Type 2 Diabetes Naturally Rating: 4 out of 5 stars4/5"Cause Unknown": The Epidemic of Sudden Deaths in 2021 & 2022 Rating: 5 out of 5 stars5/5The People's Hospital: Hope and Peril in American Medicine Rating: 4 out of 5 stars4/5As Nature Made Him: The Boy Who Was Raised as a Girl Rating: 4 out of 5 stars4/5The Big Fat Surprise: Why Butter, Meat and Cheese Belong in a Healthy Diet Rating: 4 out of 5 stars4/5The Amazing Liver and Gallbladder Flush Rating: 5 out of 5 stars5/5Peptide Protocols: Volume One Rating: 4 out of 5 stars4/5Summary of Dr. Gundry's Diet Evolution: Turn off the Genes That Are Killing You and Your Waistline Rating: 3 out of 5 stars3/5Tight Hip Twisted Core: The Key To Unresolved Pain Rating: 4 out of 5 stars4/5Working Stiff: Two Years, 262 Bodies, and the Making of a Medical Examiner Rating: 4 out of 5 stars4/5The 40 Day Dopamine Fast Rating: 4 out of 5 stars4/5
Reviews for Human Vaccines
0 ratings0 reviews
Book preview
Human Vaccines - Kayvon Modjarrad
2014;15(10):895–899.
Part I
Designing Vaccines From a New Starting Point
Outline
Chapter 1 Broadly Neutralizing Antibodies
Chapter 1
Broadly Neutralizing Antibodies
L. Morris¹ and T.A. Moody², ¹National Institute for Communicable Diseases, Johannesburg, South Africa, ²Duke University, Durham, NC, United States
Abstract
Effective vaccines for a number of human pathogens are lacking. In general, vaccines mimic natural protective immune responses. Thus, the improved ability to harness the native power of the human immune system and isolate pathogen-specific antibodies is helping to fill an important gap in vaccine development. Here we highlight the technological advances that have fast-tracked the discovery of new anti-infective monoclonal antibodies (mAbs). We discuss their role in a reverse vaccinology approach toward facilitating the design of better immunogens. We also review the development of mAbs as biological drugs to both prevent and treat infectious diseases. This chapter will focus mainly on human immunodeficiency virus type 1 and influenza virus but will also discuss other pathogens where significant progress has been made, as in the case of respiratory syncytial virus. These technologies are applicable across different diseases, providing a platform for tackling new or reemerging pathogens, such as Ebola viruses. The emergence and expansion of monoclonal antibody technologies herald a new era in the fight against infectious diseases.
Keywords
Monoclonal antibodies; neutralization; single B cell sorting; B cell culture; high-throughput screening; next-generation sequencing; reverse vaccinology; human immunodeficiency virus; influenza
The antibody response to human pathogens is generally robust, highly specific, long-lasting and, in many cases, able to clear infection. The initial encounter between a naïve B cell receptor (BCR) and a foreign antigen activates B cell clonal lineages that subsequently undergo somatic hypermutation and selection in a process that increases antibody affinity. In most cases, the first detectable antibody response in the plasma is of the IgM class, switching to IgG and IgA classes within several weeks after infection. As most high-affinity antibodies develop, B cells engage CD4+ T follicular helper cells in germinal centers and exit as plasmablasts. Intermediate IgM and class-switched memory B cells are also released into circulation at predictable intervals during the process.¹,² Large quantities of antibodies are produced by short-lived plasmablasts that are found in the circulation during an acute infection. These cells appear in particularly high numbers in response to human immunodeficiency virus type 1 (HIV-1), although the vast majority are not HIV-1-specific because of extensive B cell hyperactivation that is a hallmark of the disease.³ For those infections that are cleared, resolution is associated with a decline in the circulating plasmablast and retention memory B cell pools that are available for recall upon subsequent exposures. Consequently, secondary responses are more rapid, generate higher affinity antibodies and mediate protection against reinfection or at least severe disease.
The BCR is an integral membrane form of the antibody that is specific to each B cell. Antibodies are heterodimeric proteins consisting of heavy and light chains that combine to form a basic Y
shaped structure. Both surface-bound and secreted antibodies have a compartmentalized construction that includes a region able to recognize antigens. The process of antibody gene rearrangement⁴ results in a large array of antibody binding sites that are further diversified by somatic hypermutation.⁵ Each antibody contains two antigen recognition sites making up each arm of the Y
shaped structure. These portions—the fragment antigen binding
or Fab regions—are the primary focus of efforts to isolate and characterize human antibodies. The third major functional and structural component of an antibody is the fragment constant
or Fc region that defines antibody isotypes and subclasses. It interacts with effector arms of the immune system either by binding receptor molecules (e.g., plasma complement proteins) or by binding cell surface receptors on effector cells (e.g., NK cells). These Fc-mediated effector functions likely play an important role in a number of infections as they enhance the antiviral efficacy of antibodies. Antibody functions can be further manipulated through recombinant engineering of the Fc region, either by mutating amino acid residues, changing glycosylation patterns, or both. This has been a common practice for the development of monoclonal antibodies (mAbs) in clinical